🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to message these profiles directly for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and claims of rapid UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Some experts stated the demand for the experimental drug could be linked to the rising cost of approved slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for human use under the British medical regulations.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.

Service Response and Content Elimination

According to the social media company, the service has removed problematic material and banned associated hashtags and query recommendations. The company said it was dedicated to keeping the service secure and investing in enhancing compliance measures.

Online Trading Operations

Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, populated with images of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at residence.

After minutes of entering one community, a seller shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Details and Costs

Inside these communities, messages display dark colored packages with postal service labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how much time a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service stated it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they cannot confirm. Although the research behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has already seen patients injured by self-injection from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to possibly significant medical dangers”.